# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.statnews.com/2024/06/11/google-verily-glp1-weight-loss-drugs-lightpath-onduo/
NVDAAAPLAIWAYTSLALOTAMDHIMSCORNGMEData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
- Reuters
B of A Securities analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target...